Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol

Endocrinology

Volumn 143, Issue 9, 2002, Pages 3221-3229

  Yue, Wei ^a   Wang, Ji Ping ^a   Conaway, Mark ^a   Masamura, Shigeru ^b   Yuebai, Li ^a   Santen, Richard J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BREAST CANCER; CELL CYCLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN CELL; HYPERSENSITIVITY; LONG TERM EXPOSURE; MITOGENICITY; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; WILD TYPE;

BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ENZYME ACTIVATION; ENZYME INHIBITORS; ESTRADIOL; FLAVONOIDS; GENE EXPRESSION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036721523     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220186     Document Type: Article

References (43)

1. Recent advances in the clinical application of aromatase inhibitors
2. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
3. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo
4. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells
5. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells
6. Protein measurements with Folin-phenol reagent
7. Estimation of parameters in nonlinear regression models
8. Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions
9. Introduction to the E2F family: Protein structure and gene regulation
10. The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo
11. Blockade of the epidermal growth factor receptor inhibits transforming growth factor α-induced but not estrogen-induced growth of hormone-dependent human breast cancer
12. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells
13. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice
14. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: Evidence for a role of EGFR in breast cancer growth and progression
15. MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo
16. Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis
17. Modulation of the proliferative response of breast cancer cells to growth factors by estrogen
18. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I
19. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
20. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells
21. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
22. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167
23. Estrogen-induced activation of cdk4 and cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-cdk2
24. Convergence of mitogenic signaling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint
25. The antiestrogen ICI 182, 780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion
26. INK4A-mediated growth suppression
27. Expression of transcription factor E2F1 induces quiescent ceils to enter S phase
28. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S-regulatory genes
29. Distinct roles for E2F proteins in cell growth control and apoptosis
30. E2F: A nodal point in cell cycle regulation
31. Estrogens and cell-cycle regulation in breast cancer
32. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry
33. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation
34. Multifaceted regulation of cell cycle progression by estrogen: Regulation of cdk inhibitors and cdc25A independent of cyclin D1-cdk4 function
35. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
36. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
37. Investigation of the MEK-MAP kinase-Rsk pathway in human breast cancer
38. Effects of estrogen and tamoxifen on the MAP kinase cascade in experimental rat breast cancer
39. Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients
40. Bisphenol-A: An estrogenic substance is released from polycarbonate flasks during autoclaving
41. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo
42. Aromatase within the breast